Platelet Rich Plasma Testis Treatment for Infertile Men
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorStanford University
About this trial
Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.
Eligibility criteria
Qualifiers
Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Platelet rich plasma
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov